Medtecs International Corporation Ltd.

As of June 30, 2026, Medtecs International Corporation Ltd. carries a market capitalization of 63.21M, placing it among publicly traded companies globally. Its enterprise value stands at 62.01M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medtecs International Corporation Ltd.'s next confirmed earnings release is scheduled for March 1, 2027.

As of June 30, 2026, Medtecs International Corporation Ltd. has 544.91M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Medtecs International Corporation Ltd. maintains a current ratio of 3.03, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities.

As of the close on October 23, 2026, Medtecs International Corporation Ltd.'s stock has declined approximately 12.70% over the past 52 weeks. The 50-day moving average sits at 0.12, while the 200-day moving average is 0.12.

As of June 30, 2026, Medtecs International Corporation Ltd. holds 29.45M in cash and equivalents against 27.62M in total debt, resulting in a net debt position of 6.53M. Total book value stands at 131.92M, with working capital of 62.85M providing operational flexibility.

Medtecs International Corporation Ltd.'s most recent stock split took place on April 29, 2004 with a 5:6 split ratio.